Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Novartis AG Director's Dealing 2018

May 15, 2018

940_dirs_2018-05-15_4900e885-2b00-43e2-9eb8-2cd000bd63c1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AveXis, Inc. (AVXS)
CIK: 0001652923
Period of Report: 2018-05-15

Reporting Person: NOVARTIS AG (10% Owner)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock, par value $0.0001 36816476 Indirect

Footnotes

F1: These shares are owned directly by Novartis AM Merger Corporation, an indirect wholly-owned subsidiary of Novartis AG.